CD8A and COVID-19: After the emergence of COVID-19, early studies examined the phenotypes and functions of various subtypes of immune cells from infected patients using high-dimensional techniques, including scRNA-seq and multi-parameter cytometry.2,3 These studies also revealed the profiles of CD8+ and CD4+ T cells in patients with COVID-19.